Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran

Today, heart failure is one of the leading causes of death and disability in most developed and developing countries. By 2030, more than 23.3 million people are projected to die of cardiovascular diseases each...
Source: Health Economics Review - Category: Health Management Authors: Tags: Research Source Type: research